Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 32

Trial Status

Completed10
Other2

Role Distribution

Principal Investigator12
PI Rate100%

Activity Timeline

Clinical Trials (12)

NCT03826160Completed
Growth Hormone Dynamics and Cardiac Steatosis in HIV
Cardiac DiseaseHuman Immunodeficiency VirusLipodystrophy
PrincipalinvestigatorStart date: 2019-01-30
NCT00006158Phase 2Completed
AIDS Wasting in Women: Anabolic Effects of Testosterone
AIDS Wasting Syndrome
Principalinvestigator
NCT00100698Not ApplicableCompleted
Physiologic Growth Hormone Effects in HIV Lipodystrophy
AIDSHIV Infections
Principalinvestigator
NCT00111358Not ApplicableCompleted
Study of Lifestyle Modification in HIV Lipodystrophy
HIVMetabolic Diseases
Principalinvestigator
NCT00123253Phase 3Completed
TH9507 in Patients With HIV-Associated Lipodystrophy
HIV InfectionsLipodystrophy
Principalinvestigator
NCT00608023Phase 3Completed
TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy
HIV InfectionsLipodystrophy
Principalinvestigator
NCT01098045Completed
HIV Fat Redistribution and the Evaluation of Brown Fat
HIV Infections
Principalinvestigator
NCT01263717Not ApplicableCompleted
Effects of Growth Hormone Releasing Hormone in HIV
HIVHIV Lipodystrophy
Principalinvestigator
NCT01405456Not ApplicableCompleted
Eplerenone in HIV Associated Abdominal Fat Accumulation
HIV
Principalinvestigator
NCT01488409Phase 2Completed
Effects of Acipimox on Mitochondrial Function in Obesity
Abdominal ObesityHypertriglyceridemiaInsulin Resistance
Principalinvestigator

Showing 10 of 12 trials

Research Network

Collaboration Network

5 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Martin Torriani, MD

Massachusetts General Hopsital

Related
1 trials

Shared therapeutic areas:

HIV Infections

Worked with same sponsors:

Beth Israel Deaconess Medical CenterMassachusetts General Hospital
Collaborated on 1 trial
Similarity Score14%

Takara Stanley, MD

Massachusetts General Hospital

Related
4 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease

Worked with same sponsors:

Massachusetts General Hospital
Collaborated on 1 trial
Similarity Score14%

Pablo Tebas, MD

University of Pennsylvania

Related
14 trials

Shared therapeutic areas:

HIV InfectionsHIV
Similarity Score5%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver DiseaseObesity, Abdominal
Similarity Score5%

Sonia Caprio, MD

Yale University

Related
9 trials

Shared therapeutic areas:

Insulin ResistanceNon-alcoholic Fatty Liver Disease

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score5%

Jack A Yanovski, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
23 trials

Shared therapeutic areas:

Metabolic DiseasesInsulin Resistance

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score5%

Jamie Ostroff, PhD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Acquired Immunodeficiency SyndromeHIV
Similarity Score5%

Samuel Klein, MD

Washington University School of Medicine

Related
30 trials

Shared therapeutic areas:

Insulin ResistanceNon-alcoholic Fatty Liver Disease

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score5%

Michael Roden, Prof., MD

German Diabetes Center

Related
16 trials

Shared therapeutic areas:

Insulin ResistanceNon-alcoholic Fatty Liver Disease
Similarity Score5%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

HIV
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (12)

Showing 12 of 12 trials

NCT03826160PrincipalInvestigator

Growth Hormone Dynamics and Cardiac Steatosis in HIV

Cardiac DiseaseHuman Immunodeficiency VirusLipodystrophy
Completed
NCT00006158Phase 2PrincipalInvestigator

AIDS Wasting in Women: Anabolic Effects of Testosterone

AIDS Wasting Syndrome
Completed
NCT00100698Not ApplicablePrincipalInvestigator

Physiologic Growth Hormone Effects in HIV Lipodystrophy

AIDSHIV Infections
Completed
NCT00111358Not ApplicablePrincipalInvestigator

Study of Lifestyle Modification in HIV Lipodystrophy

HIVMetabolic Diseases
Completed
NCT00123253Phase 3PrincipalInvestigator

TH9507 in Patients With HIV-Associated Lipodystrophy

HIV InfectionsLipodystrophy
Completed
NCT00608023Phase 3PrincipalInvestigator

TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

HIV InfectionsLipodystrophy
Completed
NCT01098045PrincipalInvestigator

HIV Fat Redistribution and the Evaluation of Brown Fat

HIV Infections
Completed
NCT01263717Not ApplicablePrincipalInvestigator

Effects of Growth Hormone Releasing Hormone in HIV

HIVHIV Lipodystrophy
Completed
NCT01405456Not ApplicablePrincipalInvestigator

Eplerenone in HIV Associated Abdominal Fat Accumulation

HIV
Completed
NCT01488409Phase 2PrincipalInvestigator

Effects of Acipimox on Mitochondrial Function in Obesity

Abdominal ObesityHypertriglyceridemiaInsulin Resistance
Completed
NCT01632592Not ApplicablePrincipalInvestigator

Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue

Abdominal Obesity
Withdrawn
NCT06166797PrincipalInvestigator

Elucidating Growth Hormone Dynamics at Stages of Progressive Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease
Unknown

All 12 trials loaded